Kathleen Butler
Incyte Corporation · AstraZeneca
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kathleen Butler as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 16:53 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05073458 · Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic AnemiaIncyte Corporation · terminated · Warm Autoimmune Hemolytic Anemia (wAIHA) · study director
- Ph2NCT05061693 · A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo NodularisIncyte Corporation · completed · Prurigo Nodularis · study director
- Ph3NCT04530344 · Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With VitiligoIncyte Corporation · completed · Vitiligo · study chair
- Ph3NCT04057573 · Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)Incyte Corporation · completed · Non-segmental Vitiligo · study director
- Ph3NCT04052425 · Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)Incyte Corporation · completed · Non-segmental Vitiligo · study director
- Ph2NCT03780166 · A Study of the Safety and Tolerability of INCB050465 in Pemphigus VulgarisIncyte Corporation · withdrawn · Pemphigus Vulgaris · study director
- Ph2NCT03627065 · A Study of INCB050465 in Primary Sjögren's SyndromeIncyte Corporation · completed · Primary Sjögren's Syndrome · study director
- Ph2NCT03607487 · A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis SuppurativaIncyte Corporation · completed · Hidradenitis Suppurativa · study director
- Ph2NCT03569371 · A Study of the Safety of INCB054707 in Participants With Hidradenitis SuppurativaIncyte Corporation · completed · Hidradenitis Suppurativa · study director
- Ph2NCT03538041 · A Study of INCB050465 in Participants With Autoimmune Hemolytic AnemiaIncyte Corporation · completed · Autoimmune Hemolytic Anemia · study director
- Ph2NCT03099304 · A Study of INCB018424 Phosphate Cream in Subjects With VitiligoIncyte Corporation · completed · Vitiligo · study director
- Ph2NCT02553330 · A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)Incyte Corporation · terminated · Alopecia Areata · study director
- Ph1NCT00738842 · Uric Acid Study in Healthy Male VolunteersAstraZeneca · completed · Gout, Coronary Artery Disease · study director
- Ph1NCT00733265 · Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy VolunteersAstraZeneca · completed · Renal Impairment · study director
- Ph1NCT00685906 · AZD6140 Oral Contraceptive Interaction StudyAstraZeneca · completed · Healthy · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 16:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 16:53 UTC. The ranking covers the 200 most relevant of 98 PubMed records, and a shared surname and initials can bring in a namesake. All 98 on PubMed
- 932 citationsRCR 25.6
- Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.Circulation · 2010374 citationsRCR 10.3
- 240 citationsRCR 21.8
- Absorption, distribution, metabolism, and excretion of ticagrelor in healthy subjects.Drug Metab Dispos · 2010215 citationsRCR 5.8
- 215 citationsRCR 11.9
- Dideoxyinosine in children with symptomatic human immunodeficiency virus infection.N Engl J Med · 1991199 citationsRCR 7.0
- A Comparison of Psychological Response, Body Image, Sexuality, and Quality of Life between Immediate and Delayed Autologous Tissue Breast Reconstruction: A Prospective Long-Term Outcome Study.Plast Reconstr Surg · 2016171 citationsRCR 8.6
- Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y(12) receptor antagonist, in healthy subjects.Eur J Clin Pharmacol · 2010168 citationsRCR 4.8
- Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial.J Acquir Immune Defic Syndr · 2018161 citationsRCR 8.7
- A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006).J Clin Oncol · 2023159 citationsRCR 19.4